(Q33289104)

English

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis (English)

1 reference

Europe PubMed Central

25 July 2017

0 references

fatty liver disease

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

object named as

Ancha Baranova

5

0 references

Lance A. Liotta

8

object named as

Lance A Liotta

1 reference

Europe PubMed Central

25 July 2017

author name string

Valerie S Calvert

1

1 reference

Europe PubMed Central

25 July 2017

Rochelle Collantes

2

1 reference

Europe PubMed Central

25 July 2017

Hazem Elariny

3

1 reference

Europe PubMed Central

25 July 2017

Arian Afendy

4

1 reference

Europe PubMed Central

25 July 2017

Michael Mendoza

6

1 reference

Europe PubMed Central

25 July 2017

Zachary Goodman

7

1 reference

Europe PubMed Central

25 July 2017

Emanuel F Petricoin

9

1 reference

Europe PubMed Central

25 July 2017

Zobair M Younossi

10

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

46

1 reference

Europe PubMed Central

25 July 2017

1

1 reference

Europe PubMed Central

25 July 2017

166-172

1 reference

Europe PubMed Central

25 July 2017

Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

21 January 2018

Nonalcoholic fatty liver disease: an agenda for clinical research

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Approach to the diagnosis and treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic steatohepatitis and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic and proteomic technologies for individualisation and improvement of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Microarray technology in the study of obesity and non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping normal and cancer cell signalling networks: towards single-cell proteomics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Spatio-temporal kinetics of growth hormone receptor signaling in single cells using FRET microscopy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of mitogen-activated protein kinase (MAPK) activation in the rat pineal gland.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Inferring pathways and networks with a Bayesian framework

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity and the role of adipose tissue in inflammation and metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipokines: inflammation and the pleiotropic role of white adipose tissue

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Signalling mechanisms regulating lipolysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome and adipocytokines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21688

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21688

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33289104&oldid=2145263485"